Literature DB >> 1891556

Daily stressors and systemic lupus erythematosus: a longitudinal analysis--first findings.

E M Wekking1, A J Vingerhoets, A P van Dam, J C Nossent, A J Swaak.   

Abstract

Patients with systemic lupus erythematosus (SLE) and a comparison group of patients with rheumatoid arthritis (RA) completed the Dutch Everyday Problem Checklist and the Dutch Arthritis Impact Measurement Scale measuring physical and psychosocial aspects of illness. Both scales were completed 9 times at 6-week intervals. In addition several hematological and serological parameters were assayed. Analysis over several time points resulted in only weak correlations between the variables under study. The most remarkable finding of this study was that in SLE patients number and intensity of daily stressors are more strongly related to physical and psychosocial status than in RA patients.

Entities:  

Mesh:

Year:  1991        PMID: 1891556     DOI: 10.1159/000288416

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  3 in total

1.  Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study.

Authors:  M Haupt; S Millen; M Jänner; D Falagan; R Fischer-Betz; M Schneider
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

2.  Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist.

Authors:  C Grootscholten; G Ligtenberg; R H W M Derksen; K M G Schreurs; J W de Glas-Vos; E C Hagen; A W L van den Wall Bake; T W J Huizinga; F H J van den Hoogen; M Bijl; J C van Houwelingen; F J Snoek; J H M Berden
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

3.  Neuropsychological patterns in systemic lupus erythematosus patients with depression.

Authors:  Elizabeth Kozora; David B Arciniegas; Lening Zhang; Sterling West
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.